Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"WHO International Clinical Trials Registry Platform"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Cardiovascular%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
/vufind/Search/Results?lookfor=%22Cardiovascular%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
Search /vufind/Search2/Results?lookfor=%22Cardiovascular%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
PubPharm (17.862)
1
A study evaluating the efficacy and safety of ralinepag in treatment of patients with pulmonary hypertension. : A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients - ADVANCE-Outcomes
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Efficacy and safety of trimetazidine in patients with angina having been treated by dilatation of coronary arteries. : The efficAcy and safety of Trimetazidine in Patients withangina pectoris having been treated by percutaneous CoronaryIntervention. ATPCI studyAn international, multicentre, randomised, double-blind, placebo-controlled study in patients treated for 2 to 4 years.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
Safety, Tolerability, and Effect of Alirocumab in High Cardiovascular Risk Patients with Severe Hypercholesterolemia Not Adequately Controlled with Conventional Lipid-modifying Therapies : A Multi-Country, Multicenter, Single-Arm, Open-Label Study to Document the Safety, Tolerability and Effect of Alirocumab on atherogenic lipoproteins in High Cardio-Vascular Risk Patients With Severe Hypercholesterolemia Not Adequately Controlled With Conventional Lipid-Modifying Therapies - APPRISE
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
Safety of dabigatran etexilate in blood clot prevention in children : Open label, single arm safety prospective cohort study of dabigatran etexilate for secondary prevention of venous thromboembolism in children from 0 to less than 18 years
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
Study to test a new drug to treat patients with Pulmonary Arterial Hypertension (PAH) : An Open-label, Dose-escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of GSK2586881 in Participants with Pulmonary Arterial Hypertension - PH 2a, SD, DE, safety, PK/PD study of GSK2586881 in Pulmonary Arterial Hypertension pts
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
A Randomized, Placebo-controlled Phase 2b Study to Evaluate the Safety and Efficacy of MEDI6012 in Acute ST Elevation Myocardial Infarction : A Randomized, Placebo-controlled Phase 2b Study to Evaluate the Safety and Efficacy of MEDI6012 in Acute ST Elevation Myocardial Infarction - REAL-TIMI 63B
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
A clinical study in humans of a new drug (dutogliptin) with an existing drug (filgrastim) for use after a heart attack. : A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Dutogliptin in Combination with Filgrastim in Early Recovery Post-Myocardial Infarction - REC-DUT-002
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
A study evaluating the efficacy and safety of ralinepag in treatment of patients with pulmonary hypertension. : A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients - ADVANCE-Outcomes
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
An open-label extension (OLE) study to evaluate the long-term safety and efficacy of ralinepag in patients with pulmonary arterial hypertension : A StuDy EVAluatiNg the Long-Term EffiCacy and Safety of RalinEpag in Subjects with PAH via an Open-Label EXTENSION - ADVANCE-extension
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
Efficacy and safety of rivaroxaban in reducing the risk of major thrombotic vascular events in subjects with peripheral artery disease undergoing peripheral revascularization procedures of the lower extremities. : An international, multicenter, randomized, double-blind, placebo-controlled phase 3 trial investigating the efficacy and safety of Rivaroxaban to reduce the risk of major thrombotic vascular events in patients with symptomatic peripheral artery disease undergoing lower extremity revascularization procedures - VOYAGER PAD
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[1787]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Medienart
17.862
Aufsätze
17.862
E-Artikel
17.862
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
17.862
610
16.090
Study Type: Interventional
8.620
Recruitment Status: Not yet recruiting
4.590
Phase: Phase 3
3.146
Recruitment Status: Completed
3.002
Recruitment Status: Authorised-recruitment may ...
2.286
Phase: Phase 2
2.002
Recruitment Status: Recruiting
1.562
Study Type: Observational
1.520
Phase: Phase 4
332
Phase: Phase 1
290
Recruitment Status: Complete: follow-up complete
222
Medical Condition: Cardiovascular disease
186
Recruitment Status: Active, not recruiting
180
Recruitment Status: Stopped early
122
Medical Condition: cardiovascular disease
100
Recruitment Status: Withdrawn
94
Medical Condition: Cardiovascular diseases
90
Phase: Phase 2/Phase 3
80
Recruitment Status: Complete: follow-up continuing
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
10.528
2020-
7.334
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
17.540
Englisch
204
Unbestimmt
38
Spanisch
26
Niederländisch
14
Französisch
10
Finnisch
8
Italienisch
6
Dänisch
6
Deutsch
4
Portugiesisch
2
Tschechisch
2
Galizisch
2
Norwegisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...